Ana Muntanola Prat, Fernando Martin-Moro, Xabier Gutiérrez, Sofía Vázquez-Díaz, Lucía Morais, Itxaso Amarika, Ramón Diez-Feijóo, Mariana Bastos-Oreiro, Beatriz De La Cruz, Javier Marco, Sergio Ramos, Ana Jiménez Ubieto, Pablo Galindo, Juan Correa, Esperanza Lavilla-Rubira, Cristina García Herce, Miriam Moreno, Eva Domingo Domenech, Nazaret Dominguez, Aránzazu Alonso Alonso, María José Otero, Alessandra Comai, Maria Luisa Bengochea, Carolina Villegas Da Ros, Norma Gutierrez, Rafael Lluch-García, Sara Fernandez-Luis, Joan-Alfons Soler, Jimena Cannata, Angeles Medina, Sofia Martin-Consuegra, Marta Aceituno, Paola Villafuerte Gutiérrez, Jose Maria Arguiñano, Dunia De Miguel, Javier Lopez, Lucia Villalon Blanco, Horacio Martín, Armando Lopez-Guillermo, Antonio Salar. "Spanish real-life practice confirms zanubrutinib as a safe and effective option in relapsed or refractory marginal zone lymphoma: Results of a cohort of 118 patients on behalf of GELTAMO.." Blood, 2025. doi:10.1182/blood-2025-5350